Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Alembic Pharmaceuticals Ltd

APLLTD.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Small Cap Analyst: BUY

Last Close

$8.42

▼ -1.69%

Market Cap $1.65B · Vol 37.81K

Key Metrics

P/E Ratio

22.77

FWD: 19.78

Market Cap

$1.65B

Small Cap

Div Yield

1.49%

Annual dividend

EPS Growth

+7.63%

YoY

RSI (14)

41.64

Momentum

Beta

1.07

vs Market

52W High

$10.46

25.17% below

52W Low

$6.66

24.00% above

Volume

37.81K

Avg 102.93K

P/B

2.30

Price-to-book

ROE

125.43%

Return on equity

Free Float

29.33%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Alembic Pharmaceuticals Ltd (APLLTD.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does APLLTD.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.60%

+0.69%

+5.35%

+8.54%

YTD

-5.09%

-17.89%

-7.77%

+7.45%

Financials & Valuation

TTM · Annual

Total Revenue	$785.91M
Net Income	$71.78M
Revenue Growth (YoY)	+25.66%
Gross Margin	63.38%
Operating Margin	10.93%
Net Profit Margin	9.13%
ROE	125.43%
ROA · ROIC	8.39% · 11.30%

P/E Ratio	22.77
Forward P/E (FY1)	19.78
PEG Ratio	1.23
P/S	1.77
P/B	2.30
P/FCF	64.92
EPS Growth	+7.63%
Outstanding Shares	196.56M

Technical Indicators

50-Day SMA	$8.51
200-Day SMA	$8.31
RSI (14)	41.64
Beta	1.07
52-Week High	$10.46
52-Week Low	$6.66

Volume Today	37.81K
Avg Daily Volume (30D)	102.93K
Relative Volume	0.37x
Volatility (10D)	12.26
Volatility (30D)	21.28
Free Float	29.33%

Analyst Consensus

BUY

Current Price $8.42

Mean Target $9.76

52W Low$6.66 52W High$10.46

Current

Target

$6.66 $10.46

Current Analyst target

+15.91% upside potential · 9 analysts

Identifiers

ExchangeNSE India

FIGIBBG001T968D8

ISININE901L01018

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 2, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -1.06% JNJ Johnson & Johnson +0.04% ABBV Abbvie Inc +0.48% NVS Novartis AG +1.24% NOVN.S Novartis AG +1.25%

Company Profile

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.